Calcium carbonate 16 mg/mL and sodium alginate 50 mg/mL and sodium hydrogen carbonate 26.7 mg/mL oral suspension
RxNorm 2690207
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2690207 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Calcium carbonate 16 mg/mL and sodium alginate 50 mg/mL and sodium hydrogen carbonate 26.7 mg/mL oral suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Calcium carbonate 16 mg/mL and sodium alginate 50 mg/mL and sodium bicarbonate 26.7 mg/mL oral suspension
(Atom ID: 12902195)
SY
Synonym (SY):
Calcium carbonate 16 mg/mL and sodium alginate 50 mg/mL and sodium hydrogen carbonate 26.7 mg/mL oral suspension
(Atom ID: 12902196)
FN